- Associated Press - Wednesday, August 19, 2015

EAST PROVIDENCE, R.I. (AP) - Rhode Island has joined 48 other states in reaching a $71 million settlement with a national biopharmaceutical company.

State Attorney General Peter Kilmartin says Rhode Island will receive about $760,000 from the settlement with Amgen Inc. announced Tuesday.

The case alleged that the California-based company unlawfully promoted biologic medications Aranesp and Enbrel.

Aranesp is used to treat certain types of anemia by stimulating bone barrow to produce red blood cells. Enbrel is used to treat various conditions, including plaque psoriasis.

The company runs a plant in West Greenwich that makes Enbrel.

Kilmartin says the company engaged in deceptive marketing practices and potentially jeopardized patient health in order to boost their bottom line.

Copyright © 2019 The Washington Times, LLC.

The Washington Times Comment Policy

The Washington Times welcomes your comments on Spot.im, our third-party provider. Please read our Comment Policy before commenting.


Click to Read More and View Comments

Click to Hide